1299 related articles for article (PubMed ID: 25837886)
1. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
[TBL] [Abstract][Full Text] [Related]
4. Encephaloduroarteriosynangiosis (EDAS) in young patients with cerebrovascular complications of sickle cell disease: Single-institution experience.
Winstead M; Sun PP; Martin K; Earl J; Neumayr L; Hoppe C; Vichinsky E
Pediatr Hematol Oncol; 2017 Mar; 34(2):100-106. PubMed ID: 28532265
[TBL] [Abstract][Full Text] [Related]
5. Encephaloduroateriosynangiosis (EDAS) in the management of Moyamoya syndrome in children with sickle cell disease.
Alamri A; Hever P; Cheserem J; Gradil C; Bassi S; Tolias CM
Br J Neurosurg; 2019 Apr; 33(2):161-164. PubMed ID: 28616936
[TBL] [Abstract][Full Text] [Related]
6. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
[TBL] [Abstract][Full Text] [Related]
7. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
Pandey P; Steinberg GK
J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
[TBL] [Abstract][Full Text] [Related]
8. Encephaloduroarteriosynangiosis for pediatric moyamoya disease: long-term follow-up of 100 cases at a single center.
Zhang Y; Bao XY; Duan L; Yang WZ; Li DS; Zhang ZS; Han C; Zhao F; Zhang Q; Wang QN
J Neurosurg Pediatr; 2018 Aug; 22(2):173-180. PubMed ID: 29856299
[TBL] [Abstract][Full Text] [Related]
9. Pial synangiosis for moyamoya syndrome in children with sickle cell anemia: a comprehensive review of reported cases.
Kennedy BC; McDowell MM; Yang PH; Wilson CM; Li S; Hankinson TC; Feldstein NA; Anderson RC
Neurosurg Focus; 2014 Jan; 36(1):E12. PubMed ID: 24380478
[TBL] [Abstract][Full Text] [Related]
10. Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease.
Terrell D; Savardekar AR; Whipple SG; Dossani RH; Spetzler RF; Sun H
World Neurosurg; 2020 May; 137():62-70. PubMed ID: 32014541
[TBL] [Abstract][Full Text] [Related]
11. Bifrontal encephalogaleosynangiosis for children with moyamoya disease.
Ogiwara H; Morota N
J Neurosurg Pediatr; 2012 Sep; 10(3):246-51. PubMed ID: 22816605
[TBL] [Abstract][Full Text] [Related]
12. Surgical Revascularization for Pediatric Patients with Sickle Cell Disease and Moyamoya Disease in the Prevention of Ischemic Strokes: A Single-Center Case Series and a Systematic Review.
Aguilar-Salinas P; Hayward K; Santos R; Agarwal V; Sauvageau E; Hanel RA; Aldana PR
World Neurosurg; 2019 Mar; 123():435-442.e8. PubMed ID: 30496928
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.
Mirre E; Brousse V; Berteloot L; Lambot-Juhan K; Verlhac S; Boulat C; Dumont MD; Lenoir G; de Montalembert M
Eur J Haematol; 2010 Mar; 84(3):259-65. PubMed ID: 19912310
[TBL] [Abstract][Full Text] [Related]
14. Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure.
Fryer RH; Anderson RC; Chiriboga CA; Feldstein NA
Pediatr Neurol; 2003 Aug; 29(2):124-30. PubMed ID: 14580655
[TBL] [Abstract][Full Text] [Related]
15. Moyamoya syndrome as a risk factor for stroke in Saudi children. Novel and usual associations.
Salih MA; Murshid WR; Al-Salman MM; Abdel-Gader AG; Al-Jarallah AA; Alorainy IA; Hassan HH; Kentab AY; Van Maldergem L; Othman SA; El-Desouki MI; Elgamal EA
Saudi Med J; 2006 Mar; 27 Suppl 1():S69-80. PubMed ID: 16532134
[TBL] [Abstract][Full Text] [Related]
16. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
Smith ER; McClain CD; Heeney M; Scott RM
Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
[TBL] [Abstract][Full Text] [Related]
17. The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults.
Imai H; Miyawaki S; Ono H; Nakatomi H; Yoshimoto Y; Saito N
World Neurosurg; 2015 May; 83(5):691-9. PubMed ID: 25655688
[TBL] [Abstract][Full Text] [Related]
18. Down syndrome and moyamoya: clinical presentation and surgical management.
See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
[TBL] [Abstract][Full Text] [Related]
19. Encephaloduroarteriosynangiosis for adult intracranial arterial steno-occlusive disease: long-term single-center experience with 107 operations.
Gonzalez NR; Dusick JR; Connolly M; Bounni F; Martin NA; Van de Wiele B; Liebeskind DS; Saver JL
J Neurosurg; 2015 Sep; 123(3):654-61. PubMed ID: 26067617
[TBL] [Abstract][Full Text] [Related]
20. Encephaloduroarteriosynangiosis for hemorrhagic moyamoya disease: long-term outcome of a consecutive series of 95 adult patients from a single center.
Wang QN; Bao XY; Zhang Y; Zhang Q; Li DS; Duan L
J Neurosurg; 2019 Jun; 130(6):1898-1905. PubMed ID: 29999465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
